Skip to content
10-K

Annual Report

American CryoStem Corporation

0001019056-22-000053

← back to feed
Filed
Jan 13, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Jan 12, 2022 43.44M sh
Operating Cash Flow FY 2021 · Sep 30, 2021 −$303.92K
Operating Cash Flow FY 2021 · Sep 30, 2020 −$514.65K
Cash And Equivalents FY 2021 · Sep 30, 2021 $8.24K
Cash And Equivalents FY 2021 · Sep 30, 2020 $41.76K
Cash And Equivalents FY 2021 · Sep 30, 2019 $23.8K
Stockholders Equity FY 2021 · Sep 30, 2021 −$1.85M
Stockholders Equity FY 2021 · Sep 30, 2020 −$421.2K
Stockholders Equity FY 2021 · Sep 30, 2019 −$1.24M
Current Liabilities FY 2021 · Sep 30, 2021 $1.63M
Current Liabilities FY 2021 · Sep 30, 2020 $1.05M
Total Liabilities FY 2021 · Sep 30, 2021 $2.9M
Total Liabilities FY 2021 · Sep 30, 2020 $1.9M
Current Assets FY 2021 · Sep 30, 2021 $196.95K
Current Assets FY 2021 · Sep 30, 2020 $567.16K
Total Assets FY 2021 · Sep 30, 2021 $1.06M
Total Assets FY 2021 · Sep 30, 2020 $1.48M
Rd Expense FY 2021 · Sep 30, 2021 $374.28K
Rd Expense FY 2021 · Sep 30, 2020 $19.18K
Net Income FY 2021 · Sep 30, 2021 −$2.88M
Net Income FY 2021 · Sep 30, 2020 −$1.18M
Operating Income FY 2021 · Sep 30, 2021 −$2.75M
Operating Income FY 2021 · Sep 30, 2020 −$900.54K
Gross Profit FY 2021 · Sep 30, 2021 $7.02K
Gross Profit FY 2021 · Sep 30, 2020 $514.07K
Cost Of Revenue FY 2021 · Sep 30, 2021 $13.57K
Cost Of Revenue FY 2021 · Sep 30, 2020 $43.84K
Revenue FY 2021 · Sep 30, 2021 $20.59K
Revenue FY 2021 · Sep 30, 2020 $557.9K
Capex FY 2021 · Sep 30, 2020 $3.88K